Stockwinners Market Radar for March 19, 2024 - Earnings, Upgrades downgrades, option trades, Best Stock Advisory Service

21:01 EDT Sunrise New Energy discloses Nasdaq listing requirement notice - Sunrise "announced that it has received a letter from the Nasdaq Stock Market LLC on March 14, 2024, notifying the Company that it no longer meets the minimum bid price requirement set forth in the Nasdaq Listing Rules. The Notification Letter has no immediate impact on the listing or trading of the Company's shares on Nasdaq. The Notification Letter does not affect the Company's business operations, its U.S. Securities and Exchange Commission reporting requirements, or contractual obligations. Nasdaq Listing Rule 5550(a)(2) requires listed securities to maintain a minimum bid price of US$1.00 per share, and Nasdaq Listing Rule 5810(c)(3)(A) provides that a failure to meet the minimum bid price requirement exists if the deficiency continues for a period of 30 consecutive business days. Based on the closing bid price of the Company's Class A ordinary shares for the 30 consecutive business days from January 30, 2024 to March 14, 2024, the Company no longer meets the minimum bid price requirement."

18:05 EDT ZTO Express sees FY24 parcel volume up 15%-18% y/y - Based on current market conditions and current operations, the company's parcel volume for 2024 is expected to be in the range of 34.73B-35.64B, representing a 15%-18% increase year over year.

18:02 EDT ZTO Express upsizes share repurchase program by $500M

17:46 EDT Prosperity Bancshares receives regulatory approval for Lone Star acquisition - Prosperity Bancshares, the parent company of Prosperity Bank, announced that it has received all regulatory approvals necessary to complete its previously announced acquisition of Lone Star State Bancshares, the parent company of Lone Star State Bank of West Texas. The merger is expected to be effective as of April 1 subject to the satisfaction or waiver of customary closing conditions described in the definitive merger agreement. Lone Star banking locations will continue to operate under the Lone Star name until the operational integration, which is scheduled for October 28. At that time, Lone Star customers may begin using any of Prosperity Bank's combined 288 banking centers. Upon completion of the merger, Prosperity's West Texas Area will have 49 banking centers.

17:00 EDT Gildan to contact other potential bidders in light of recent media reports - Gildan issued the following statement in response to recent media reports: "In response to the receipt of a confidential non-binding expression of interest to acquire Gildan, Gildan's Board formed a Special Committee of independent directors to, among other things, review and consider the merits of the proposal and any alternative transaction, including maintaining the status quo and continuing to execute on Gildan's existing business plan. After consulting with its legal and financial advisors and considering the interests of Gildan's shareholders and other stakeholders, the Special Committee determined that it was consistent with its fiduciary duties and in the best interests of Gildan to contact other potential bidders with a view to maximizing the value of any potential transaction. The Special Committee, with the assistance of its financial advisors, conducted targeted outreach to a small number of reputable potential counterparties. Several of these counterparties expressed an interest in considering a potential friendly transaction with Gildan. There can be no assurance any transaction will result from these discussions, and Gildan will continue to provide updates as appropriate."

16:50 EDT InterDigital's Hakoranta sells over $403K in shares - InterDigital officer Eeva Hakoranta disclosed the sale of 3,910 shares of company stock at $103.17 per share on March 19, for a total transaction amount of $403,395.

16:38 EDT Aeon: EOP2 meeting with FDA productive, defined primary endpoint for Phase 3 - Aeon Biopharma announced a productive end-of-Phase 2, EOP2, meeting with the U.S. Food and Drug Administration FDA following the Phase 2 data in episodic migraine previously released in October 2023, that supports advancing ABP-450 or prabotulinumtoxinA injection into the proposed pivotal Phase 3 program. As part of the updated development plan, the Company will now conduct an interim analysis of the ongoing Phase 2 study of ABP-450 for the preventive treatment of chronic migraine and anticipates releasing the data in the second quarter of 2024. "We are pleased to announce a productive end-of-Phase 2 meeting with the FDA, during which we aligned on the proposed study design and the primary endpoint for the pivotal Phase 3 program with ABP-450 injection for the preventive treatment of episodic and chronic migraine," commented Marc Forth, President and Chief Executive Officer of AEON. "The insights from our Phase 2 study in episodic migraine were well received by regulators and provide an exciting next step to conduct an interim analysis of the ongoing Phase 2 program in chronic migraine with the same primary endpoint we plan to utilize in the proposed Phase 3 trials. With data from over 300 participants that have completed the two 12-week treatment cycles, the interim analysis of the Phase 2 study in chronic migraine is statistically powered to show efficacy."

16:36 EDT Stellantis announces pact with CARB - Stellantis announced a partnership with the California Air Resources Board, or CARB. As part of the agreement with CARB, Stellantis pledged to expand its ongoing commitment to strengthen its electrification offensive through educational efforts for U.S. consumers and dealers on the benefits of electric vehicles, or EV. This includes collaborating with Veloz, the leader in promoting EV awareness efforts, providing discounted EVs to organizations in disadvantaged communities, and building upon ongoing efforts and contributing an additional $10M for the installation of public EV chargers.

16:34 EDT Gilead to contact other potential bidders in light of recent media reports - Gildan issued the following statement in response to recent media reports: "In response to the receipt of a confidential non-binding expression of interest to acquire Gildan, Gildan's Board formed a Special Committee of independent directors to, among other things, review and consider the merits of the proposal and any alternative transaction, including maintaining the status quo and continuing to execute on Gildan's existing business plan. After consulting with its legal and financial advisors and considering the interests of Gildan's shareholders and other stakeholders, the Special Committee determined that it was consistent with its fiduciary duties and in the best interests of Gildan to contact other potential bidders with a view to maximizing the value of any potential transaction. The Special Committee, with the assistance of its financial advisors, conducted targeted outreach to a small number of reputable potential counterparties. Several of these counterparties expressed an interest in considering a potential friendly transaction with Gildan. There can be no assurance any transaction will result from these discussions, and Gildan will continue to provide updates as appropriate."

16:32 EDT Corporacion America Airport reports February traffic up 5.4% from last year - Corporacion America Airports reported a 5.4% year-on-year increase in passenger traffic in February 2024, reaching 92.8% of February 2019 levels. International passenger traffic surpassed pre-pandemic levels by 4.2%, while domestic traffic stood at 89.7% of February 2019 levels.

16:30 EDT Raymond James CEO Paul Reilly to step down in 2025, Paul Shoukry to succeed - Raymond James announced that as part of its multi-year succession planning process, effective immediately, CFO Paul Shoukry is appointed president of Raymond James Financial. It's expected that he will become the firm's CEO sometime during fiscal 2025, following a transition period. Once the planned succession process is complete, Shoukry would become only the fourth chief executive in the company's history, and current chair and CEO Paul Reilly would remain on the board as executive chair. Shoukry will retain his current responsibilities until he transitions to the CEO role. As part of the firm's succession plans, Raymond James is announcing other key leadership changes and appointments. Jeff Dowdle has announced that he will be retiring and stepping down from the COO role at the end of the fiscal year. As part of this change, Raymond James Financial Private Client Group president Scott Curtis will become COO of Raymond James Financial, current Raymond James & Associates CEO Tash Elwyn will become president of the Private Client Group, and Global Equities & Investment Banking President Jim Bunn will become president of the Capital Markets segment. These changes will be effective October 1, at which time Dowdle will be named vice chair and serve in an advisory role to facilitate a transition.

16:22 EDT Corvus to initiate Phase 1 trial of soquelitinib for AD in Q2 - In February , the U.S. Food and Drug Administration or FDA, granted Orphan Drug Designation for soquelitinib for the treatment of T cell lymphoma, providing potential benefits including assistance in the drug development process, tax credits for clinical costs, exemptions from certain FDA fees and seven years of post-approval marketing exclusivity. The Company has also obtained alignment with FDA on its protocol for a registrational Phase 3 clinical trial of soquelitinib in patients with relapsed PTCL and anticipate initiating the trial in the third quarter of 2024. There are currently no FDA fully approved agents for the treatment of relapsed PTCL. Corvus plans to initiate a randomized, placebo-controlled Phase 1 trial of soquelitinib in patients with moderate to severe atopic dermatitis in the second quarter of 2024, with the potential for initial data from the trial before year end 2024.

16:20 EDT Nyxoah announces DREAM study meets primary endpoints - Nyxoah announced the DREAM U.S. pivotal study achieved a statistically significant reduction in the co-primary endpoints of 12-month AHI responder rate, per the Sher criteria, and ODI responder rate, both on an ITT basis. The DREAM study is a trial, being conducted under an investigational device exemption and is designed to support the marketing authorization of the Genio hypoglossal nerve stimulation system, or HGNS, in the United States. This multicenter, prospective, open-label, interventional study enrolled 115 patients and has co-primary efficacy endpoints of the Apnea-Hypopnea Index, or AHI, responder rate, per the Sher criteria, and the Oxygen Desaturation Index, or ODI, responder rate, both measured at 12 months. Subjects also were required to sleep supine for at least 60 minutes at their 12-month polysomnography test, or PSG. Study participants entered the DREAM study with a mean AHI of 28.0, mean ODI of 27.0 and mean body mass index of 28.5. At 12 months, 73 subjects were determined to be AHI responders, per the Sher criteria, resulting in an ITT AHI responder rate of 63.5%, and 82 subjects were determined to be ODI responders, resulting in an ODI responder rate of 71.3%. Subjects demonstrated a median 12-month AHI reduction of 70.8%, with similar AHI improvements in supine and non-supine sleeping positions. The safety results for the investigational treatment were favorable, with 11 serious adverse events, or SAEs, in ten subjects resulting in an SAE rate of 8.7%. Out of the 11 SAEs, three were device related and there were three explants.

16:18 EDT Amcor CEO Ron Delia to retire, Peter Konieczny named interim CEO - Amcor announced that after nine years as CEO, Ron Delia has informed the Board of Directors of his decision to retire from the company and step down from the Board for health reasons, effective April 15. The Board has appointed Peter Konieczny, Amcor's current Chief Commercial Officer and a long-standing member of the company's Global Management Team, as Interim CEO. Delia will provide continued support in an advisory role until September 30 to facilitate the transition. The Board is conducting a thorough search process to identify a permanent successor for the CEO role, which will include internal and external candidates.

16:17 EDT American Outdoor Brands announces settlement agreement with Vista and Bushnell - American Outdoor Brands announced that it has reached an amicable settlement agreement with Vista Outdoor Sales and Bushnell Holdings to settle pending patent litigation. On May 30, 2023, AOB filed a complaint against Vista alleging that, through Vista's sales of the RCBS ChargeMaster Supreme Electronic Powder Dispenser, Vista was infringing AOB's patent rights incorporated in the Frankford Arsenal Intellidropper electronic powder measure. On August 1, 2023, Bushnell filed a complaint against AOB alleging that, through AOB's sales of certain hunting blind products, AOB was infringing Bushnell's patent rights under U.S. Pat. Nos. 7,475,699, 7,717,124, and 7,984,725. As a result of the settlement, the two cases have been dismissed. No further details of the settlement will be provided.

16:08 EDT Benchmark Electronics announces resignation of CFO Roop Lakkaraju - Benchmark Electronics announced Roop K. Lakkaraju, Executive Vice President and CFO intends to resign from his position to pursue another professional opportunity outside of Benchmark. Lakkaraju will remain in his current role until April 1. Effective April 1 Arvind Kamal, Benchmark's current Vice President of Finance, will assume the role of interim CFO. Kamal has been with Benchmark for more than 4 years and has a deep understanding of the EMS sector. During this transition, Kamal's leadership capabilities across both finance and accounting position him well to continue Benchmark's ongoing pursuit of our financial objectives. Over the coming months, the company intends to conduct a formal search process to identify Benchmark's next chief financial officer.

16:06 EDT China Jo-Jo Drugstore regains Nasdaq compliance - China Jo-Jo Drugstores announced that it received a letter from the Listing Qualifications Department of The Nasdaq Stock Market on March 15, notifying the company that it has regained compliance with the Nasdaq Capital Market's minimum bid price requirement and the matter is closed.

15:50 EDT Box sees long-term gross margin of 82%-83% - Box said it will deliver "sustainable growth and continued margin expansion" in slides for the company's investor day meeting.

15:17 EDT ESPN, College Football Playoff extend media rights agreement through 2031 season - ESPN and the College Football Playoff, or CFP, have reached a pair of media agreements that ensures ESPN will continue as the exclusive, worldwide rightsholder to college football's postseason event through the 2031-32 season. The exclusive home of the CFP since its inception in 2015, ESPN will expand its current package for the final two years, adding all four of the new first round games each year to ESPN's existing New Year's Six and the CFP National Championship rights in the new 12-team playoff that will launch this Fall. In addition, ESPN has secured a new, six-year agreement - beginning in the 2026-27 season - for the entire CFP, which includes exclusive rights to all rounds of the expanded playoff - first round, quarterfinal, semifinal and National Championship, as well as continued exclusive rights to all ancillary programming connected to the playoff, such as the CFP Selection Show, weekly Top 25 Rankings Shows and more. In both the amended two-year agreement and new six-year extension, the CFP provides ESPN with the right to sublicense a select number of games. Beginning in the 2026-27 season, ESPN will broadcast the CFP National Championship on ABC in addition to offering its MegaCast presentation across ESPN platforms. In all, the new agreement includes expansive rights to simulcast or MegaCast CFP games across all Disney platforms, including TWDC Direct-to-Consumer offerings. The new, six-year agreement also provides expanded sales and sponsorship opportunities that will cement Disney Advertising as the exclusive seller of the College Football Playoff Official Partner Program and broaden Disney Advertising's ability.

14:11 EDT Gildan Activewear trading halted, news pending

13:47 EDT Cabaletta Bio treatment of systemic sclerosis granted orphan designation - Cabaletta Bio's treatment of systemic sclerosis was granted orphan designation by the FDA, according to a post to the agency's website. Reference Link

13:19 EDT Arbe Robotics says 'thrilled to be part of the NVIDIA sensor ecosystem' - Arbe Robotics tweeted: "Arbe is thrilled to be part of the NVIDIA sensor ecosystem! NVIDIA is spearheading revolutionary autonomous system advancements with Omniverse Cloud APIs, providing autonomous vehicle AI developers with a top-notch simulator." Reference Link

12:41 EDT Block says commercial real estate shakeout in 'early innings' - Carson Block of Muddy Waters is speaking on Bloomberg TV.

12:23 EDT Takeda announces FDA approval of supplemental indication for Iclusig - Takeda announced that the Food and Drug Administration has approved the supplemental new drug application for Iclusig for the treatment of adult patients with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia in combination with chemotherapy. The indication is approved under accelerated approval based on minimal residual disease-negative complete remission at the end of induction. Continued approval for this indication may be contingent upon verification and description of clinical benefit in confirmatory trials, the company said.

12:00 EDT Skillsoft falls -9.0% - Skillsoft is down -9.0%, or -76c to $7.68.

12:00 EDT Nordstrom rises 11.3% - Nordstrom is up 11.3%, or $1.94 to $19.00.

12:00 EDT Aeva Technologies rises 442.6% - Aeva Technologies is up 442.6%, or $4.47 to $5.48.

11:31 EDT Takeda leukemia treatment granted accelerated approval by FDA - The Food and Drug Administration said it granted accelerated approval to Takeda Pharmaceuticals' ponatinib with chemotherapy for adult patients with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia. Reference Link

11:03 EDT Check Point, Nvidia collaborate to enhance security of AI cloud infrastructure - Check Point Software Technologies (CHKP) is collaborating with NVIDIA (NVDA) to enhance the security of AI cloud infrastructure. Integrating with NVIDIA DPUs, the new Check Point AI Cloud Protect solution will help prevent threats at both the network and host levels. The rapid proliferation of AI has brought about a revolution in workplace efficiency and innovation. However, this growth also creates additional attack vectors specifically targeting AI, such as backdooring AI models to control a model's output or to gain unauthorized access to the environment, data exfiltration to expose intellectual property, and denial of service to degrade performance and reduce capacity. These threats compromise the integrity and security of AI systems and pose risks to business outcomes. Check Point aims to address these challenges with NVIDIA by integrating network and host-level security insights, offering a comprehensive solution that protects AI infrastructures from both conventional and novel cyber threats. This integrated approach helps ensure the security system is cognizant of network activities and host-level processes, which is crucial for safeguarding AI's future.

10:36 EDT Aptorum Group Ltd trading resumes

10:28 EDT Oppenheimer ordered to pay $1M by CFTC over records lapses - The Commodity Futures Trading Commission issued two orders simultaneously filing and settling charges against U.S. Bank, a swap dealer, and against Oppenheimer, an introducing broker, for failing to maintain and preserve records that were required to be kept under CFTC recordkeeping requirements and failing to supervise matters related to their businesses as CFTC registrants. The orders require U.S. Bank to pay a $6M civil monetary penalty and Oppenheimer to pay a $1M civil monetary penalty. Reference Link

10:04 EDT Datasea enters manufacturing agreement with Broadway Precision Technology - Datasea announced that the Company's wholly-owned subsidiary, Shuhai Jingwei entered into a Manufacturing Cooperation Agreement with Broadway Precision Technology, a wholly-owned subsidiary with factories in China, Thailand, Mexico and the US of Shanghai Yongli Belt Industry. The Agreement marks an important step for Datasea in the production and deployment of its newly upgraded hi-tech intelligent acoustic deodorization and disinfection products. According to the Agreement, Broadway will provide injection molding and production services for the Company newly upgraded hi-tech intelligent deodorization and disinfection models. The manufacturing schedule of the company's products will be synchronized with our market and sales demands, facilitating ongoing negotiations with several key clients for product orders which we expect to sign in the near-term.

10:00 EDT Digital Equipment Corporation falls -8.0% - Digital Equipment Corporation is down -8.0%, or -94c to $10.85.

10:00 EDT Nuscale Power falls -24.5% - Nuscale Power is down -24.5%, or -$2.47 to $7.63.

10:00 EDT Spire Global rises 42.2% - Spire Global is up 42.2%, or $5.18 to $17.46.

09:48 EDT Capybara says 'failing company' SoundHound worth '$1 per share or less' - In a recently published report titled "Lies, Damned Lies, and Cheeseburger 'AI'," Capybara Research says it is short SoundHound (SOUN), calling it "a failing company peddling lies and deception." Capybara believes SoundHound is "misleading investors about their AI capabilities" and is "hiding the fact that it has lost some of its biggest customers," including Mercedes-Benz (MBGYY), Deutsche Telekom (DTEGY), and Netflix (NFLX). "SoundHound went public via a SPAC merger and used fantasy projections to sell their failing business to retail investors. The company continues to use these metrics to hoodwink investors," the report reads. Capybara believes SoundHound is "worth $1.00 per share or less. Most of that value is from their accumulated net operating losses which can be used to offset future tax liabilities. The company's technology is a commodity and has little value in the crowded and hyper-competitive voice recognition market." Shares of SoundHound have slid about 8% to $7.60 in morning trading. Reference Link

09:47 EDT Huya falls -10.6% - Huya is down -10.6%, or -50c to $4.22.

09:47 EDT CVR Partners rises 6.7% - CVR Partners is up 6.7%, or $4.28 to $68.00.

09:47 EDT Aeva Technologies rises 407.9% - Aeva Technologies is up 407.9%, or $4.12 to $5.13.

09:41 EDT Nordstrom up 12% after report founders renewing effort to take company private

09:38 EDT ShiftPixy trading resumes

09:34 EDT FibroBiologics announces preliminary proof of concept for diabetes treatment - FibroBiologics announced the progress of a clinical program under development using a fibroblast-based pancreatic beta cell spheroid that secretes insulin in vitro upon glucose stimulation. The development and reproducibility of this work demonstrates that an organoid composed of fibroblasts, beta cells and other components can successfully and durably secrete insulin. "This early proof of concept is encouraging and may lead to a new and durable potential allogeneic treatment option for people with insulin-dependent diabetes," said Hamid Khoja, Ph.D., Chief Scientific Officer. "We look forward to confirming these early results and in vivo utility. We will then determine whether to designate the program as an early phase pre-clinical project for developing a minimally invasive therapeutic for type 1 diabetes."

09:32 EDT Medigus: Charging Robotics announces installment of wireless charging system - Medigu announced that Charging Robotics has successfully completed the installation of its wireless charging system for an automated parking system. To the best of Charging Robotics' knowledge, this is the first installation of a wireless charging system for automatic car parks. This system was installed by Charging Robotics in an automatic car park facility in Tel Aviv, Israel together with the provider of this facility under a pilot project intended to verify the performance of the system. The system reaches a charging power of 10kW and includes managed charging capabilities to meet a limited supply of electricity and prioritize the charging process. The system includes a user interface installed on the driver's smart phone, which is used to operate the system, receive updates on the charging process, generate billing reports and other useful information.

09:30 EDT Nordstrom trading halted, volatility trading pause

09:30 EDT Nocturne Acquisition Corp trading halted, volatility trading pause

09:14 EDT CEL-SCI: LEAPS vaccine offers 'new paradigm to treat' RA published in Frontiers - CEL-SCI Corporation announced the peer-reviewed scientific journal Frontiers in Immunology published an article regarding CEL-SCI's Ligand Epitope Antigen Presentation System or LEAPS, technology in the treatment of rheumatoid arthritis,RA, titled: "Current status of immunological therapies for rheumatoid arthritis with a focus on antigen-specific therapeutic vaccines". CEL-SCI's LEAPS team, along with outside collaborators from U.S. and Europe, reviewed published/presented results from pre-clinical animal model of antigen-specific LEAPS therapeutic vaccines, such as CEL-4000 and CEL-5000, made specific for the treatment of RA, and compared these findings with published results of other RA-therapies that either suppress or alter the immune response in order to treat RA. ..The authors also emphasized that the most appropriate way to advance the LEAPS vaccines to the clinic would be an adaptive study design for clinical trials, enrollment of patients with early-stage RA, and using the Bayesian optimal design model, currently used in oncology studies, as well as the use of disease-related biomarkers to ascertain responsiveness to treatment and introduce additional tools to assess outcome at the disease level.

09:09 EDT Tenable Holdings delivers zero trust cloud functionality for Kubernetes - Tenable announced expanded Tenable Cloud Security cloud-native application protection platform, CNAPP, capabilities for Kubernetes on-premises and public cloud environments. These latest advancements extend Tenable's CNAPP benefits, such as contextual risk visibility, preventive security controls, and zero trust / least privilege enforcement, to Kubernetes. "Tenable Cloud Security takes the guesswork out of the entire cloud security equation, enabling security teams to reduce cloud risk in minutes," said Shai Morag, senior vice president and general manager of Tenable Cloud Security. "We're in an overly saturated market of feature-based tools that address small, inconsequential areas of risk. Tenable provides comprehensive visibility, accelerated time to value and unmatched actionable intelligence that takes the security headaches out of Kubernetes and all cloud infrastructure."

09:08 EDT Merck: V116 vaccine for pneumococcal diseases show adult immune response - Merck announced positive data from multiple Phase 3 studies evaluating V116, the company's investigational, adult-specific 21-valent pneumococcal conjugate vaccine, at the 13th Meeting of the International Society of Pneumonia and Pneumococcal Diseases or ISPPD, in Cape Town, South Africa. Across the clinical studies presented, V116 was shown to be immunogenic for all 21 serotypes covered by the vaccine in a variety of adult populations, including those who had not previously received a pneumococcal vaccine those who had previously received a pneumococcal vaccine and those with an increased risk of pneumococcal disease, including people living with human immunodeficiency virus or HIV. V116 also elicited higher immune responses than the studied comparators for the serotypes unique to V116 in all STRIDE studies presented at the meeting. "Invasive pneumococcal disease and pneumococcal pneumonia can cause serious illness, especially in older adults and those with immunocompromising conditions," said Dr. Walter Orenstein..."The extensive data presented this week reaffirm our confidence in the potential clinical value V116 could provide to a range of adult populations," said Dr. Eliav Barr, senior vice president, head of global clinical development and chief medical officer, Merck Research Laboratories. "We are encouraged by the results of these studies showing that V116 has generated immune responses to the serotypes responsible for the majority of adult invasive pneumococcal disease."

09:07 EDT iCAD releases enhanced ProFound Detection workstation - iCAD announced new, advanced workstation features for ProFound Detection for both 2D and 3D mammography in its latest V3 Service Pack update. "We're excited to introduce advanced workstation features for our flagship solution, ProFound Detection, aimed at further improving and facilitating radiologists' interpretation of mammograms within their workstation," said Dana Brown, President and CEO of iCAD. "With these new capabilities, such as limiting lesion marks to the three highest-scoring lesions, which can be color-coded based on lesion score, and providing color-coded ProFound Scorecards based on case score categories, along with options for fine-tuning based on a facility's real-world data, we're enhancing radiologists' interpretability and efficiency in cancer detection."

09:06 EDT Aetherium Acquisition announces postponement of special meeting - Aetherium Acquisition announced that the adjournment of its extraordinary general meeting of stockholders will be postponed from its scheduled time of 8:30 a.m. Eastern Time on March 18, 2024 to 8:30 a.m. Eastern Time on March 28, 2024 to procure additional votes for the Trust Amendment Proposal. The Company has prepared Amendment No. 2 to the definitive proxy on Schedule 14A to amend the Trust Amendment Proposal to delete the permission to withdraw funds from the Company's trust account to pay for excise taxes. All other proposals have been approved as of this date. The record date for the Meeting remains February 9 2024. To exercise redemption rights, holders must tender their share certificates to Continental Stock Transfer & Trust Company, Aetherium Acquisition's transfer agent, no later than two business days prior to the Meeting, which deadline is now March 26, 2024.

09:04 EDT Clover Health launches new clinical program in partnership with Quartet Health - Clover Health announced a partnership with Quartet Health to increase the support and resources provided to Clover members with serious mental illness through the Company's home-based care delivery unit, Clover Home Care. As part of this partnership, Quartet will use its expert care teams to augment Clover Home Care's capabilities. Quartet's clinicians will also begin using the Clover Assistant platform to deliver care to the Clover patients under its care. "Patients with serious mental illness often have worse outcomes and a lower life expectancy, and they experience a fragmented healthcare system that does not adequately address their behavioral, physical, and social needs," said Dr. Michael Lipp, Quartet Health's Chief Medical Officer, and former CMO of the CMS Innovation Center. "Patients often struggle to get access to care, and the care they do receive is often uncoordinated. Layered on top of Clover Assistant's data-driven insights, this program will provide care that is coordinated, comprehensive and convenient, at no additional cost to patients."

09:04 EDT Pitney Bowes CFO Ana Maria Chadwick departs, John Witek named interim CFO - Pitney Bowes announced that John Witek, who was most recently head of global business services, has been appointed interim CFO, effective March 19. Witek's appointment follows the departure of Ana Maria Chadwick, who is leaving to assume a new role with another organization. Chadwick has agreed to remain at the company as an advisor until April 21 to ensure a transition. The company has initiated a formal search process with recruitment firm Crist Kolder Associates for Chadwick's permanent replacement. The company will consider candidates with experience in areas that include business transformation, capital allocation and efficiency, cost containment, debt management and reduction, strategic restructurings, and transactions.

09:03 EDT Bayer, Lavie Bio continue biofungicides validation - Lavie Bio, a subsidiary of Evogene (EVGN), announced that it is extending its joint validation trials for its biofungicides conducted by Bayer (BAYRY), after successful first-year laboratory and greenhouse testing. The tests have demonstrated the efficacy of Lavie Bio's biofungicides in addressing devastating diseases that affect fruits and vegetables worldwide. Building on these positive outcomes, the companies are progressing to a second year of validation trials in field experiments.

09:02 EDT Scilex announces repayment of balance of convertible debentures - Scilex Holding Company has paid off the remaining balance of approx. $1,300,000 under the convertible debentures previously issued and sold to YA II PN, in March 2023. Scilex has also voluntarily made an early payment in the aggregate amount of $15,000,000 under the senior secured promissory note issued to Oramed Pharmaceuticals in September 2023.

08:46 EDT Autonomix appoints Jennifer Cook as CBO - Autonomix Medical announced the appointment of Jennifer Cook as its Chief Business Officer. Cook joins Autonomix having most recently served as the Vice President of Marketing at MedShift, a technology company helping to drive growth and scale to medical device manufacturers and healthcare providers.

08:44 EDT Foresight's Eye-Net secures follow-up order from vehicle manufacturer - Foresight Autonomous' Eye-Net Mobile has received an additional order for a paid development project from a leading global Japanese vehicle manufacturer, following the successful completion of the first two phases of a paid proof-of-concept project. As reported by the Company on February 28, 2023, the parties engaged in a paid POC project to evaluate the added value and capabilities of Eye-Zone as a software vehicle-to-everything (V2X) communication layer. The successful completion of that phase is a significant milestone, demonstrating the feasibility and potential benefits of Eye-Net's technology for the automotive industry. The parties have decided to proceed to the next phase of the project. In this phase, the vehicle manufacturer will assess the potential of Eye-Zone to act as key infrastructure for point-to-point transmission of safety messages between the vehicle and designated users in the same vicinity. This unprecedented capability will potentially facilitate seamless communication between vehicles and all road users and help, in particular, vulnerable road users. Upon successful evaluation, the parties will explore potential commercial opportunities.

08:43 EDT Nocturne Acquisition announces postponement of EGM - Nocturne Acquisition Corp. Board of Directors has voted in favor of postponing the meeting date for the Extraordinary General Meeting that was to be held on March 19, 2024 for shareholders to vote on the proposed business combination with Cognos Therapeutics. The Extraordinary General Meeting will now be held virtually on April 2, 2024 at 9:00 a.m. Eastern Time, and the Company plans to continue to solicit proxies from shareholders during the period prior to the Extraordinary General Meeting. The record date for the Extraordinary General Meeting remains the close of business on December 29, 2023. No changes have been made in the proposals to be voted on by the shareholders at the postponed meeting. Shareholders who have previously submitted their proxy or otherwise voted and who do not want to change their vote need not take any action. Stockholders as of the record date may vote, even if they have subsequently sold their shares. The deadline by which shareholders must exercise their redemption rights in connection with the Extraordinary General Meeting has been extended to two business days prior to the postponed meeting.

08:42 EDT Trio Petroleum provides update on Monterey County operations - Trio Petroleum provided an update on its operations in Monterey County, California, including at the McCool Ranch Field and at the Presidents Field. TPET is pleased to announce that the HH-1 well at McCool Ranch has been producing about 47 barrels of oil per day since it was put back on cold production on February 22, 2024. The 58X well at McCool Ranch was also put back on production but was temporarily idled in order to perform a heat treatment that should be accomplished shortly. The 35X well at McCool Ranch has been hooked-up to power and it should also be put back on production shortly. Given the success of the McCool Ranch wells, the Company plans to also restart the last two wells in the restart program, the HH-3 and HH-4 wells, in subsequent weeks. TPET is also pleased to announce that equipment and facilities have been moved to the HV-3A discovery well site at Presidents Field in the South Salinas Project and that well should be put back on production this week or next. As a result, TPET should soon have four actively producing oil wells, three at McCool Ranch Field and one at Presidents Field.

08:40 EDT Iteris awarded $3M contract by Texas DOT for 'Smart Mobility' - Iteris announced that it has been awarded a five-year indefinite delivery/indefinite quantity IDIQ contract by the Texas Department of Transportation, TxDOT, San Antonio District. The contract has a value of up to $3M representing continued demand for Iteris' specialized consulting services in the large and forward-thinking Texas market...This agreement is the sixth major contract awarded to Iteris by TxDOT in the past six years, underscoring Iteris' value in one of the largest and most progressive national transportation markets. "We are proud to be selected again by TxDOT to support important infrastructure projects in the San Antonio District," said Cliff Heise, regional vice president, mobility professional services at Iteris.

08:40 EDT R1 RCM Committee says talks with New Mountain, TCP-ASC must stop for now - In a regulatory filing, R1 RCM stated: "As previously disclosed on March 11, 2024, the Board of Directors of R1 RCM Inc. formed a special committee comprised solely of independent directors to evaluate all strategic alternatives in response to the Schedule 13D/A filed by New Mountain Capital on February 26, 2024. TCP-ASC ACHI Series LLLP subsequently filed a Schedule 13D/A on March 11, 2024. Advisors to the Special Committee include Qatalyst Partners and Barclays as financial advisors and Skadden, Arps, Slate, Meagher & Flom LLP as legal counsel. As the Special Committee works through its thorough process to determine a course of action to maximize value for all shareholders, they have directed that any discussions between New Mountain Capital and TCP-ASC concerning a potential transaction with respect to the company (whether or not structured as a joint transaction) must cease at this time. As such, the Special Committee has not approved at this time any of the standstill waivers requested by New Mountain Capital or the waivers requested by New Mountain Capital or by TCP-ASC under antitakeover statutes. No assurances can be given regarding the outcome or timing of the Special Committee's review process. The company does not intend to make any further public comment regarding the review unless and until it has approved a course of action for which further disclosure is appropriate." Reference Link

08:38 EDT Inuvo launches enhanced IntentKey Insights Dashboard - Inuvo has announced significant enhancements to its custom-designed, AI-powered Insights Dashboard, detailing target audience interests and campaign performance. Inuvo's AI was designed to solve the two biggest problems facing advertisers in a cookieless world: audience targeting and performance measurement. With this update, clients now have the information they need to make better decisions. The enhanced dashboard includes three key sections: Funnel Overview: This added view illustrates how IntentKey clients build brand awareness to drive users down the conversion funnel over time. It highlights key metrics around brand affinity, site engagement, and conversion, showcasing the customer's path to purchase. These updates allow clients to better understand the differences between audiences at different stages across the marketing conversion funnel. Model Insights: The interface already provides detailed analytics on audience insights, segments, concept drivers, AI-generated personas, television programming, and conversion likelihood by state. With the latest update, clients can now also see specifically which podcasts align with their audiences. Performance Spend Analysis: The view instantly provides Inuvo clients the power to predictively measure the impact of campaigns across marketing tactics based on their KPIs. Uniquely, this feature now empowers clients to deploy and measure cookieless versus cookie-based tactics, a capability not available with vendors whose technology requires cookies to function. With advanced Media Mix Modeling, clients can easily and accurately compare the efficiency of different programmatic tactics across devices including IOS, where cookies are no longer present.

08:36 EDT CyberArk announces two of its SaaS offerings achieve FedRAMP high ATO status - CyberArk announced that two of its leading software-as-a-service SaaS offerings, CyberArk Endpoint Privilege Manager and CyberArk Workforce Identity, have achieved Federal Risk and Authorization Management Program, FedRAMP, High authorization to operate ATO status. This authorization reinforces CyberArk's ability to help federal agencies and other public sector organizations efficiently and effectively secure access to all corporate applications, protect distributed workforces and accelerate cloud innovation in alignment with Zero Trust principles outlined in EO 14028. "Agencies must now come to terms with several cloud-based risks that lurk beneath the surface in this new technology landscape. Beyond the schemes of cybercriminals, non-malicious human error on its own has the potential to hinder mission-critical functions in the form of misconfigured networks and mismanaged controls. It's now more important than ever to adopt the Zero Trust 'never trust, always verify' mentality," said Theresa Payton, former White House CIO and member of the Cyber Defenders Council. "As new tools, technologies and threats arise, continued attention will need to be paid by government and government-adjacent regulatory programs. By adopting Zero Trust-focused compliance requirements, FedRAMP can place a greater onus on private sector organizations to launch the Federal Government efficiently and expediently into a more secure and more efficient future."

08:36 EDT Clearlake Capital Group, Insight Partners complete acquisition of Alteryx - Clearlake Capital Group and Insight Partners announced that their affiliated funds have completed the acquisition of Alteryx. The transaction was previously announced on December 18, 2023 and approved by Alteryx stockholders on March 13, 2024. As a result of the completion of the transaction, Alteryx stockholders will receive $48.25 in cash for each share of Alteryx Class A or Class B common stock that they own. Alteryx is now a privately held company and its common stock has ceased trading on the New York Stock Exchange.

08:34 EDT Scorpius Holdings awarded contract in excess of $1M with NIH-funded researcher - Scorpius Holdings announced that it has been awarded a contract in excess of $1M with an NIH-funded researcher at a major university. The program involves process optimization and development of a therapeutic antibody, which Scorpius will manufacture for preclinical studies. Jeff Wolf, CEO of Scorpius, stated, "Scorpius is excited to begin work with another nationally renowned university. Our selection by this leading researcher highlights our unique process development, bioanalysis, and manufacturing capabilities, which we have the ability to leverage into much larger projects as the programs progress through clinical stages and eventually into commercialization. There is a tremendous amount of innovative research being conducted at academic institutions, and Scorpius is well-suited to provide these clients with the attention and responsiveness they otherwise would not receive from a CDMO. Overall, we could not be more excited about the outlook for the business and the traction we are gaining."

08:33 EDT Intra-Cellular promotes Halstead to President, CFO Hineline to retire - Intra-Cellular Therapies announced the promotion of Michael Halstead, J.D. to the position of President. Halstead is currently serving as Executive Vice President and General Counsel. In this newly created leadership role, Halstead will oversee several functions within the Company including legal, human resources, manufacturing & supply chain, quality, compliance, information technology, and external innovation. He will continue to report to Dr. Sharon Mates, Chairman and Chief Executive Officer. Intra-Cellular Therapies also announced that Senior Vice President and Chief Financial Officer, CFO, Larry Hineline, will be retiring after more than 20 years of service.

08:27 EDT Hoth Therapeutics announces positive preclinical research in Alzheimer's - Hoth Therapeutics unveiled "positive" pre-clinical research involving HT-ALZ, an Alzheimer's disease therapeutic. HT-ALZ combats neuroinflammation and cognitive deficits associated with Alzheimer's Disease. By antagonizing the NK1 receptor, HT-ALZ reduces soluble Abeta levels in the brain's interstitial fluid and diminishes anxiety-like behavior and enhances cognitive function in preclinical models. The research presents evidence of HT-ALZ's capacity to improve memory tasks related to the hippocampus and sensorimotor gating. While the effects on plaque deposition and Abeta levels were inconclusive, the treatment's cognitive benefits suggest that HT-ALZ's mode of action may involve a reduction in brain inflammation, thereby improving cognitive outcomes for Alzheimer's patients. Hoth Therapeutics remains committed to further research and development of HT-ALZ, including analyses of its effects on microglial activation and brain inflammation.

08:22 EDT Catheter Precision to sponsor Monaco USA Arrhythmia Course - Catheter Precision is honored to be sponsor a session at the upcoming Monaco USA Arrhythmia Course taking place March 21-23 in Monaco. The course is organized by co-directors, Professor Nadir Saoudi, Professor of Cardiology and Chief of the Cardiology Section at the Princess Grace Medical Centre in Monaco, and Dr. Francis Marchlinski, Professor of Medicine and Director of Electrophysiology at the University of Pennsylvania, Philadelphia, Pennsylvania. They have assembled luminaires in the field of electrophysiology for a three-day educational program focused on new techniques and technologies as well as interesting cases in the treatment of cardiac arrhythmias.

08:21 EDT Forza X1 provides construction update on North Carolina facility - Forza X1 announced most of the concrete for the 60,000 square foot floor has been poured and crews are scheduled to start setting steel this week at the site of the Company's state-of-the-art manufacturing facility located on its 11-acre property in Marion, North Carolina. Forza's Executive Chairman, Interim CEO, and Chief of Product Development Joseph Visconti expressed enthusiasm about the next phase of the factory's construction, stating, "We are one step closer to realizing our vision for a cutting-edge manufacturing facility. Once it's completed, we expect our facility will be capable of producing up to 550 boats annually utilizing the latest in closed-molded composite boat building technologies. We're looking forward to seeing the construction's progress throughout the spring and into summer."

08:19 EDT Sacks Parente Golf introduces putter demo program for golfers - Sacks Parente Golf announces the launch of its demo program offering golfers the opportunity to test premium putters from the Company prior to purchase. "We are passionate about offering golfers the opportunity to experience the exceptional performance of Sacks Parente putters through our demo program," said Greg Campbell, Executive Chair of SPCG. "By bringing the trial experience directly to golfers' doorsteps, we're empowering them to make confident decisions about their equipment without the pressure of a traditional retail environment. We're confident that golfers will feel and better understand why Sacks Parente putters will help them make more putts when they test and compare our putters on their home course."

08:18 EDT K92 Mining temporarily suspends underground operations at Kainantu - K92 Mining announces that underground operations at the Kainantu Gold Mine have been temporarily suspended after a non-industrial incident occurred on the Company's mining lease on March 10, 2024, resulting in a deceased employee. Processing operations were temporarily suspended for three days and have resumed processing stockpiles. Preliminary findings from K92 and the Royal Papua New Guinea Constabulary have concluded that the death is a non-industrial suspicious incident. K92 is working with the relevant Government authorities under the Criminal Code Act and Mining Act to support their investigations. On March 13, 2023, the Mineral Resources Authority ordered a temporarily suspension of underground operations through issuance of a "Form 29", pending the completion of action orders in relation to an independent safety audit and the installation of a collision avoidance system. Work on these action orders is underway and were in process by the Company prior to the issuance of the action orders. Given the non-industrial nature of the incident, procedural, determination and jurisdictional breaches of the Mining Act in issuing the Form 29, K92 filed an appeal on March 14, 2023 and expects this to be addressed shortly. The Company is working to resolve this expeditiously and will be providing an update in due course.

08:17 EDT Nuvei selected by Charles & Keith for eCommerce payments solution - Nuvei has partnered with Charles & Keith, the Singaporean-based fashion house specializing in footwear, handbags and accessories, to optimize the brand's eCommerce payments solution as it continues its rapid global expansion. Through a single integration with Nuvei's full stack payments technology platform, Charles & Keith is now able to accept a range of alternative payment methods, tailoring its online checkout experience to local customer preferences across the brand's markets in Southeast Asia, Europe and the U.S. This includes enabling popular digital wallets such as Apple Pay and Google Pay. Nuvei's smart routing technology is also maximizing Charles & Keith's card payment authorization rates in each region.

08:16 EDT Sunrun announces partnership with Carhartt - Sunrun and Carhartt announced a partnership to make Carhartt the official apparel supplier for Sunrun and its thousands of installers, technicians and service team members. "Sunrun is committed to the safety of our hardworking employees. We know that when they have the best gear and feel comfortable and protected, they do their best work," said Chris McClellan, Sunrun's Chief Field Operations Officer. "Our team members are excited to be wearing Carhartt Company Gear as they battle extreme heat, bitter winter cold, and other everyday elements as they serve our nearly one million customers across the country."

08:14 EDT 23andMe launches feature connecting customers to historic individuals - 23andMe Holding released a new feature for 23andMe+ Premium and Total Health members, that uncovers DNA connections to 335 unique historical individuals, from medieval Vikings to late Stone Age African hunter-gatherers to pre-colonial indigenous Caribbean people to the great musical genius Ludwig Van Beethoven. 23andMe plans to add additional historical genomes to the Historical Matches feature over time, offering 23andMe+ Premium and Total Health members more opportunities to connect their stories to past epochs. To create this new feature and connect members to Historical Matches, 23andMe identifies segments of DNA that individuals share with the genetic sequences of historical individuals. The feature relies on publicly available data, scientific publications, and the 23andMe relative matching technology to link to these historical individuals. Most members will have a match to one or more of these individuals, offering them a connection to specific individuals from a particular time in history.

08:13 EDT Tonix announces transition to fully integrated biopharmaceutical company - Tonix Pharmaceuticals announced that it will achieve its goal of transitioning to a fully integrated pharmaceutical company on April 1, 2024. Since the acquisition of Zembrace SymTouch 3 mg and Tosymra 10 mg on June 30, 2023, Tonix Pharmaceuticals has been putting in place the personnel, systems and contracts required to support a commercial organization. Both products are indicated for the treatment of acute migraine with or without aura in adults. "Tonix will become a fully integrated biopharmaceutical company with a mission of developing and marketing innovative, high-value therapeutics," said Seth Lederman, M.D., Chief Executive Officer of Tonix Pharmaceuticals. "Tonix will assume responsibility for the distribution, selling and marketing of Zembrace SymTouch and Tosymra, as well as supply chain, regulatory and quality control of the two products."

08:12 EDT Cytek Biosciences Velo3D names McCombe as Chief Financial Officer - Cytek Biosciences (CTKB) announced that William McCombe has been appointed chief financial officer of the company effective immediately. McCombe brings experience as a public company CFO at both large scale, and smaller, high growth technology companies. He was CFO at Velo3D (VLD).

08:10 EDT Iveda expands partnership with EGAT for AI-powered smart drone applications - Iveda announces the expansion of its partnership with Evergreen Aviation Technologies or EGAT ," a leading aircraft maintenance solutions provider, following the success of the partnership over the past year. Together Iveda and EGAT are continuing to expand AI-powered smart drone applications around the globe in areas including the Philippines, Mexico, the U.S., and the Middle East. Growing their partnership, EGAT and Iveda will proceed with the development of military-grade smart drones, equipped with Iveda's AI Video Analytics and sensor technologies, to assist with confidential military deployments, flood and fire surveillance, border and coastal patrol, livestock tracking, remote equipment searches, infrastructure inspections, and basic aerial crowd traffic control. Having responded to multiple Requests for Proposals RFPs from both private and government entities from the countries mentioned above, the potential value of this partnership expansion exceeds $2.5M to date, with one significant RFP valued at $1.8 M. To date, the typical drone configurations requested have ranged from $90,000 to $350,000 per unit. EGAT will continue to provide Iveda with the assets, technical support, and training to facilitate the promotion and sale of its drone products on a global scale, which is especially important as Fortune Business Insights predicts the commercial smart drone market to reach $54.81B by 2030."

08:09 EDT Horizon Aircraft publishes research on trend towards urbanization - New Horizon Aircraft publishes new global research that indicates the global trend towards urbanisation is believed by Japanese private equity, venture capital and family office investors to be a key driver behind the anticipated growth in the eVTOL. The study from PureProfile, commissioned by the Company, surveyed investors in Japan responsible for more than $423 billion assets under management. It has been predicted that 65% of the global population will be living in cities by 2050, compared to 55% today, which equates to almost 2.3 billion people set to move into cities over the next 30 years. This population concentration in cities, equivalent to an additional 76 million people moving into urban areas across the globe each year, will give rise to escalating congestion in ground transportation. The need to address such transportation issues is believed by 65% of Japanese professional investors to be a key driver behind the growth of the eVTOL market. The study reveals increasing optimism about the Urban Air Mobility market with more than two in five Japanese professional investors stating they think the first commercial UAM routes will be operational by 2026, and 18% believing that the first commercial flights could be as early as 2025. Only 5% of professional investors in Japan believe the debut date for commercial passenger routes will extend beyond 2030. The future of urban mobility will require a greater reliance on eco-friendly and reliable alternative modes of transport. The study reveals that 83% of Japanese professional investors agree that regulators' support of the eVTOL market will be important in the drive to reduce the overall carbon footprint of the aviation sector. Roughly three out of four Japanese investors believe public support for eVTOLs will grow over the next three years with 18% anticipating a dramatic increase in public confidence. Just 8% of the private equity, venture capital and family office investors questioned believe public confidence in the sector will decline as the launch of the first services comes closer to reality. Around 15% do not see any change in public confidence happening or did not express an opinion. More than three in four of Japanese investors identified the use of pilots as the key to guaranteeing increased public confidence while 61% say more successful trials of passenger and drone services will be important. The same number want evidence of more regulatory improvements. Around 55% point to more news about successes in the sector and 45% are hoping for the endorsement of the sector by major companies and investors. The study found 23% of Japanese investors believe search and rescue will be the first practical use of eVTOLs while 18% think eVTOLs will be used first for supplying remote areas and 15% believe they will first be used for disaster relief. The same number believe the first use of eVTOLS will be for passenger transport and 13% believe they will be used first for organ transport. Horizon is targeting the future production of a manned seven-seat capacity hybrid electric eVTOL called the Cavorite X7 which includes room for a pilot and six passengers. It has been developed in response to demand from potential customers in the medevac, business aviation and commercial cargo sectors.

08:07 EDT Google, Microsoft and Nucor partner to aggregate demand for clean electricity - Google (GOOG), Microsoft (MSFT) and Nucor (NUE) will work together across the electricity ecosystem to develop new business models and aggregate their demand for advanced clean electricity technologies. These models will be designed to accelerate the development of first-of-a-kind and early commercial projects, including advanced nuclear, next-generation geothermal, clean hydrogen, long-duration energy storage and others. As a first step, the companies will issue an RFI in several US regions for potential projects in need of offtake, and encourage technology providers, developers, investors, utilities and others interested in responding to get in touch here. By developing new commercial structures and aggregating demand from three of the world's largest energy buyers, this approach aims to reduce the risks for utilities and developers considering early commercial projects and enable the investments that are needed - ultimately helping to bring these projects online by the early 2030s and reducing technology costs through repeated deployment. The companies will initially focus on proving out the demand aggregation and procurement model through advanced technology pilot projects in the U.S. In addition to supporting innovative technologies that can help decarbonize electricity systems worldwide, this demand aggregation model aims to bring clear benefits to large energy buyers. Pooling demand enables buyers to offtake larger volumes of carbon-free electricity from a portfolio of plants, reducing project-specific development risk, and enables procurement efficiencies and shared learnings.

08:06 EDT IonQ and SC Quantum in pact to further 'a Quantum Ecosystem in South Carolina' - IonQ announced it has entered a strategic agreement with South Carolina Quantum or SC Quantum to provide world-class quantum computing capabilities and professional services to SC Quantum partners, including academic institutions. As part of the agreement, IonQ and SC Quantum will partner to develop quantum-specific academic coursework for training future members of the quantum economy. SC Quantum will also partner with IonQ to accelerate the introduction of quantum technologies within enterprises, startups, and industries across South Carolina. With this announcement, SC Quantum becomes the latest U.S. state effort to partner with IonQ, joining other states like Maryland and Washington in recognizing the need for quantum skill sets across business, government, and academia. In 2023, South Carolina earmarked millions for SC Quantum to develop a quantum-focused workforce and build quantum-smart technologies in the state.

08:05 EDT Cerence announces equity grant to employee under inducement plan - Cerence announced that, in connection with Daniel Tempesta's recent appointment as CFO effective March 18, 2024, the Company granted Mr. Tempesta an initial equity award with a target aggregate value of $3 million. Such award consists of 102,599 time-based restricted stock units and 102,599 performance-based restricted stock units, based on the average closing price of the Company's common stock over the trailing 20 trading days ending on the date of grant. The time-based restricted stock units will vest in three equal installments on each of October 1, 2024, October 1, 2025, and October 1, 2026, in each case subject to Mr. Tempesta's continued service with the Company through the applicable vesting date. The performance-based restricted stock units will be earned based on the Company's performance upon the completion of each of fiscal year 2024, 2025, and 2026, with one-third of the total performance-based restricted stock units eligible to be earned for each fiscal year, subject to Mr. Tempesta's continued service with the Company through such vesting date. In addition, the Company granted Mr. Tempesta a one-time sign-on equity award with a target aggregate value of $3 million, consisting of 205,198 restricted stock units based on the average closing price of the Company's common stock over the trailing 20 trading days ending on the date of grant, which vests in three equal installments on each of December 15, 2024, December 15, 2025, and December 15, 2026, subject to Mr. Tempesta's continued service with the Company through such vesting date. All of these awards were granted as an inducement material to Mr. Tempesta entering into employment with the Company pursuant to Rule 5635(c)(4) of the Nasdaq Listing Rules.

08:04 EDT Morphic appoints Cooper as Chief Medical Officer - Morphic Therapeutic (MORF) announced that Simon Cooper, M.B.B.S., has joined the Company as Chief Medical Officer. Dr. Cooper most recently served as Chief Medical Officer of Keros Therapeutics (KROS).

08:03 EDT Spectral AI announces receipt of $1M financing for Spectral IP - Spectral AI has received a $1 million investment from an affiliate of its largest shareholder into its recently formed subsidiary Spectral IP. The investment is structured as a note payable with a one-year maturity, an interest rate of 8%, and requiring earlier prepayment if Spectral IP is spun off to the Company's shareholders or sold. Spectral IP will focus on advancing intellectual property in the broader AI ecosystem through acquisitions, strategic partnerships and collaborations with AI technology providers, healthcare institutions, and research organizations to accelerate innovation and expand market reach.

08:03 EDT Jasper announces first patient dosed in Phase 1b/2a SPOTLIGHT study - Jasper Therapeutics announced that the first patient has been dosed in Jasper's Phase 1b/2a clinical study of subcutaneous briquilimab for the treatment of CIndU. The SPOTLIGHT study is evaluating a single administration, at two different dose levels, of subcutaneous briquilimab in adult patients with cold urticaria or symptomatic dermographism. "We are excited to announce dosing of the first patient in the SPOTLIGHT study in patients with CIndU, our second clinical program evaluating briquilimab in a mast cell-mediated disease," said Edwin Tucker, Chief Medical Officer of Jasper. "As with our BEACON study in CSU, we expect the SPOTLIGHT study to establish proof of concept for the depletion of mast cells by briquilimab in CIndU and help us to determine doses and dosing regimens for future registrational studies. We plan to provide enrollment updates as we progress through the study and anticipate reporting preliminary data in the second half of 2024."

07:58 EDT Clearmind Medicine granted divisional patent approval in China - Clearmind Medicine has been granted divisional patent approval by the China National Intellectual Property Administration. The divisional patent approval, previously announced, grants Clearmind a broader claim than patent application. Allowed claims directed to using a primary amine aminoindan compound to regulate a binge behavior. Covers primary amine aminoindan compounds besides 5-methoxy-2-aminoindan, the company's innovative psychedelic molecule. This latest patent builds upon Clearmind's broad IP protection in the psychedelic space, which now includes 27 granted patents and 24 pending patent applications across 15 patent families, nine of which have been granted in major jurisdictions such as the US, Europe, China, and India.

07:39 EDT ARway announces paid partner deal with EWROS - ARway.ai announced a paid partner deal with EWROS, a leading developer of automation systems software based out of Turkey. This new partner is another step in ARway.ai's expansion, aligning with EWROS's recognized position in the region as a premier automation solutions provider. EWROS becomes an integral part of the ARway ecosystem, licensing ARway's innovative platform for large-scale projects within the region. This partnership allows EWROS to leverage ARway's cutting-edge AR technology in conjunction with their existing IoT deployments, thereby offering a comprehensive tech stack to their clientele.

07:37 EDT UFP Technologies announces $500M amended supply agreement with Intuitive Surgical - In a regulatory filing on Monday night, UFP (UFPT) said that the company, though a wholly owned subsidiary, and Intuitive Surgical SARL (ISRG), one of the company's strategic medical customers, entered into that certain amendment to the manufacturing supply agreement dated April 25, 2014 as amended. Pursuant to the terms of the Amended Supply Agreement, among other things, for an initial four-year period commencing January 1, 2024, the Customer has agreed to purchase the majority of certain products from the company on a semi-exclusive basis. The Amended Supply Agreement also provides for volume-based pricing terms based on certain minimum purchase thresholds. The Amended Supply Agreement provides for automatic renewal for additional one-year terms following the initial term, subject to certain early termination rights for bankruptcies and uncured, material breaches held by both parties and non-renewal rights held by both parties. We currently estimate that sales under the Amended Supply Agreement will result in approximately $500M in revenue over the initial term of the Amended Supply Agreement if the Customer buys the specified number of products to take advantage of volume-based pricing under the Amended Supply Agreement. Should the Customer choose not to buy the specified annual or aggregate volumes it would not receive the agreed-upon pricing provided under the Amended Supply Agreement.

07:36 EDT Brookfield Asset Management appoints Hadley Peer Marshall as CFO - The Board of Brookfield Asset Management announced the appointment of Hadley Peer Marshall as CFO effective May 31, 2024. Ms. Peer Marshall joined Brookfield in New York in 2015 in the Infrastructure Group where she is co-head of infrastructure debt and structured solutions. Peer Marshall will continue in her role in infrastructure in addition to her new responsibilities as CFO. She succeeds Bahir Manios as CFO of Brookfield Asset Management, a role in which he has served since creation as a separate, publicly traded company in 2022. Manios has decided to retire from Brookfield. He will remain CFO through the announcement of first quarter earnings results until May 31, and continue as a strategic advisor to ensure a smooth transition.

07:34 EDT DavidsTea launches 'Tea-2-Go' at over 1,500 Couche-Tard/Circle K stores - DAVIDsTEA announced it has secured an exclusive supplier agreement with Alimentation Couche-Tard to offer a premium "Tea-2-Go" in-store experience at over 1,500 convenience stores across Canada. "We are proud to become the exclusive supplier of high-quality teas across Canada to an industry leader like Couche-Tard," said Sarah Segal, Chief Executive Officer and Chief Brand Officer, DAVIDsTEA. "This landmark agreement enables DAVIDsTEA to introduce a whole new segment of customers to our wide variety of flavourful teas. It also represents a key step in our omnichannel growth strategy to expand our footprint while driving profitable growth."

07:33 EDT PTC Therapeutics provides regulatory updates - PTC Therapeutics submitted a BLA to the FDA for Upstaza, a gene therapy for the treatment of aromatic L-amino acid decarboxylase deficiency, a fatal, rare genetic disorder that typically causes severe disability and suffering from the first months of life. In addition, based on recent feedback from the FDA, PTC plans to re-submit an NDA for Translarna for the treatment of nonsense mutation Duchenne muscular dystrophy, a rare and fatal genetic disorder that results in progressive muscle weakness from early childhood and leads to premature death in the mid-20's. PTC expects to make the NDA resubmission by mid-year. In addition, the sepiapterin MAA for PKU remains on schedule for submission to the EMA by the end of this month. The efficacy and safety profile of Upstaza has been demonstrated across clinical trials and compassionate use programs. The first patient was dosed in 2010. Upstaza has received marketing authorization in Europe, Great Britain and Israel.

07:26 EDT Howard Hughes enters JV patnership with Discovery Land Company - Howard Hughes announced a joint venture partnership with Discovery Land Company for the development of a new residential tower, 'Ilima Ward Village, in the premier location within the acclaimed 60-acre master planned community of Ward Village in the heart of Honolulu. 'Ilima is designed to deliver an unrivaled island living experience with a refined aesthetic, expansive amenities, and sweeping ocean and Diamond Head views. 'Ilima, along with its companion tower Melia Ward Village, is being designed by celebrated architecture firm Robert A.M. Stern Architects.

07:22 EDT Diversified Energy provides updated capital allocation framework - Since first initiated in 2017, Diversified has delivered more than $800 million in cash returns to the Company's stockholders, including approximately $700 million in cash dividends, along with approximately $110 million in share repurchases, and the Board remains committed to maintaining a sustainable and competitive shareholder return policy. The Company has undertaken a reassessment of its capital allocation strategy to weigh the intrinsic value of the current share price level against the historical practice of returning capital through dividends. The Board and executive management team have jointly evaluated a number of potential scenarios to align the dividend level with expected future capital allocation needs, peer trends, current commodity prices, and current equity market dynamics. The result of this assessment is the Board's realignment of capital allocation and is designed to best position the Company to create long-term shareholder value through the balanced combination of: Systematic debt reduction; Fixed per-share dividend; Strategic share repurchases; Accretive strategic acquisitions. In conjunction with the asset acquisition and following the Company's capital allocation policy review, the Board has set the new quarterly dividend to $0.29 per share which equates to $1.16 per year. This fixed quarterly dividend payment will be sustainable for at least three years and maintains a top quartile pro forma yield1, among FTSE350 and higher than a majority of US listed peers, while providing the Company financial flexibility to reallocate approximately $110 million annually of capital towards the other elements within the updated capital allocation framework. When combined with our planned debt reduction through amortization of approximately $200 million in 2024, the capital allocation framework will allow for an opportunity to meaningfully reduce leverage and remain within the Company's stated target leverage range of 2.0x to 2.5x. In addition, the Company will have increased flexibility to conduct a strategic and regimented share repurchase program, while also providing for the opportunity to make accretive acquisitions. The updated capital allocation framework will take effect with the recommended final dividend for 2023, payable in June 2024.

07:19 EDT Diversified Energy reports 2023 average net daily production 821 MMcfepd - Total Revenue grew 2% to $1B. CEO Rusty Hutson, Jr. commented: "We finished the year with strong financial, operational, and sustainability results, which reflect the continued execution and success of our business strategy and the contributions of our teams. Despite headwinds in the natural gas market, Diversified grew annual adjusted EBITDA by approximately 8%, increased margins by approximately 6%, and generated $219 million in free cash flow. From a capital allocation perspective, we reduced our outstanding debt by approximately 15% since our interim results while returning $180 million in capital to shareholders in 2023 through dividends and strategic share repurchases. The highly accretive transaction announced today increases our Central Region opportunities and reinforces our commitment to a highly disciplined growth strategy."

07:14 EDT Heart of the Harvest picks ReposiTrak traceability network for FDA requirements - Family-run Heart of the Harvest parent company, Capitol Sausage and Provisions, whose expansive operations include wholesale fruits and vegetables as well as pre-cut offerings, has automated food traceability with the ReposiTrak Traceability Network RTN . Through RTN, the company can collect a complex set of FDA-required Key Data Elements KDEs from each of its hundreds of valued suppliers, from any of the suppliers' systems. Use of RTN enables Heart of the Harvest to meet and exceed the requirements of the FDA's FSMA 204 food traceability law. "As a processor and distributor of many of the foods covered by the FDA's food traceability law, there was no reason for us to wait to do food traceability," said Lisa Driscoll of the quality assurance team at Heart of the Harvest. "We recognize that it takes time to get suppliers connected and to get the data flowing, and we have found a solution that makes it easy and affordable to do traceability now." The ReposiTrak Traceability Network requires no additional hardware or software and the ReposiTrak team assists in making the connections needed under the new regulation. Suppliers can connect to an unlimited number of trading partners and begin sharing data for a low, flat fee and there is no cost to retailers.

07:11 EDT Aya Gold & Silver secures 6 new permits, provides update at Boumadine - Aya Gold & Silver announces that it has completed 50% of its airborne MobileMT geophysical survey and secured the right to 6 exploration permits at its Boumadine Project in the Kingdom of Morocco. Its Boumadine exploration portfolio now totals up to 141.4 square kilometers. "We are excited to consolidate further and increase our footprint by 70%, as our largest annual drill program ever at Boumadine continues to exceed expectations and indicate significant potential," said Benoit La Salle, President & CEO. "Our confidence continues to grow with additional drill results, and we expect our geophysics, hyperspectral and ground mapping to generate valuable data to define quality drill targets on the permits."

07:10 EDT Enveric in out-licensing deal for chemical entities to treat joint diseases - Enveric Biosciences is pleased to announce that it has signed two non-binding term sheets with an undisclosed biotechnology company to pursue the out-licensing of cannabinoid-COX-2 conjugate compounds for both pharmaceutical and non-pharmaceutical applications for the treatment of joint diseases. The term sheets contemplate that, for all human and animal joint pathology, such as osteoarthritis, rheumatoid arthritis, and other joint pathology applications, the undisclosed licensee would assume responsibility for all future product development efforts and in return would receive exclusive, royalty-bearing global licenses to develop, market and sublicense the compounds. The compounds are new chemical entities that include cannabinoids in conjugate form with COX-2 inhibitors and cannabinoids in conjugate form with selected steroids. The pharmaceutical application term sheet provides that Enveric could be eligible to receive future development and sales milestone payments that in total could add up to approximately $61M, assuming certain conditions are met, including receiving approval for the investigational new drug IND application and completing Phases I through III testing of the licensed product. Royalty rates could range from 2.5% up to 10% on future sales, depending on meeting certain sales criteria. The non-pharmaceutical application term sheet provides that Enveric could be eligible to receive future development and sales milestone payments, which in total could add up to approximately $21 million and with royalty rates ranging from 0.25% up to 7%, assuming certain conditions are met, including successful product development and commercial launch and on meeting certain sales criteria. Together, through the out-licensing of the two assets and meeting various development and sales milestones, Enveric could potentially receive milestone payments that total up to approximately $82M...

07:08 EDT Paramount Gold announces BLM filed Notice of Intent for Grassy Mountain - Paramount Gold Nevada announces that the Bureau of Land Management, BLM, has filed the Notice of Intent in the Federal Registry, thereby initiating the preparation of an Environmental Impact Statement in compliance with the National Environmental Policy Act process for the proposed Grassy Mountain mine. Paramount's President & COO, Glen van Treek, stated, "The filing of the NOI in the federal registry marks a major milestone, providing a definitive path forward towards the construction and operation of the Grassy Mountain mine. The development of Grassy Mountain offers significant potential to provide much-needed employment opportunities and economic growth to Malheur County," van Treek added. The filing of the NOI follows the completeness determination by the BLM of the Plan of Operation for Grassy Mountain as announced on November 29, 2022.

07:05 EDT Conduit Pharmaceuticals appoints Holland as Chief Scientific Officer - Conduit Pharmaceuticals announced the appointment of Dr. Joanne Holland as Chief Scientific Officer. Dr. Holland brings over 20 years of experience to the CSO role at Conduit, having amassed expertise across the entire development spectrum.

07:05 EDT Main Street makes follow-on $40.0M investment in Gulf Manufacturing - Main Street recently completed a follow-on investment in an existing portfolio company. Main Street made the investment in Gulf Manufacturing to support the company's acquisition of Maass Global Group, a manufacturer and distributior of flanges and specialty forged products, forged bar, seamless pipe, and fittings in duplex, stainless steel, and high nickel alloys. Main Street's follow-on investment consists of a $40.0M first lien, senior secured term debt investment. Main Street also provided GMI with a revolving line of credit to support the company's future growth initiatives and working capital needs. As a result of the acquisition, a new parent holding company, Gulf Manufacturing Holdings, was formed to own GMI and Maass. Founded in 1984 and located in Humble, Texas, GMI is a manufacturer and supplier of fittings, flanges, and specialty products for the oil and gas industry. With existing manufacturing and distribution locations in Humble, TX and Broussard, LA, GMI serves customers throughout the U.S. Main Street has been invested in GMI since 2007. Post-transaction, the combined company will operate globally with manufacturing and distribution operations in the U.S., Europe and Asia.

07:03 EDT Tourmaline Bio sees cash runway into 2027 - Cash, cash equivalents and investments were $203.0 million as of December 31, 2023, as compared to $8.3 million as of December 31, 2022. Tourmaline anticipates that its current cash, cash equivalents and investments as of the date hereof, which includes $161.3 million of net proceeds received from the January 2024 underwritten public offering, will provide cash runway into 2027, funding key TOUR006 data readouts in TED and cardiovascular disease and the opportunity to expand development efforts into additional indications.

07:02 EDT Roku and Cross Screen Media expand partnership for cross-channel measurement - Roku announced an expanded partnership with Cross Screen Media, a CTV activation managed service provider for local agencies specializing in political and public affairs. Cross Screen Media's agency customers can now accurately measure spend on Roku inventory and through Roku's Ad Platform. Agencies can also leverage Roku's ACR viewership data to target precise audiences based on household-level consumption of ads across both linear TV and CTV. The expanded partnership augments the existing capability for agencies to efficiently reach their target audiences by activating campaigns on Roku's premium inventory through unique first-party data.

07:00 EDT Airbus ends discussions with ATOS on potential acquisition of BDS - Airbus stated: "After careful consideration of all aspects of a potential acquisition of ATOS' BDS - Big Data and Security - business line, Airbus has decided it will no longer pursue discussions with ATOS about this potential transaction."

06:52 EDT Phreesia names Jack Callahan as new Chief Technology Officer - Phreesia has named Jack Callahan as the company's new Chief Technology Officer. Callahan previously served as Phreesia's Vice President of Engineering and has been with the company for 14 years. He succeeds Dan Nathan, who has been with the company for 17 years and played an integral role in establishing Phreesia's technical capabilities. Nathan will remain with the company as Senior Engineering Advisor.

06:36 EDT Reddit to evaulate Nokia's patent infingement claims - In a regulatory filing, Reddit (RDDT) said Nokia (NOK) sent the company a letter indicating they believed that Reddit infringes certain of their patents. "We will evaluate their claims," Reddit said in the filing."

06:33 EDT Matrix Service enters strategic relationship with Geldof for EPC solutions - Matrix Service's subsidiary Matrix PDM Engineering has signed a Memorandum of Understanding with Engicon nv Geldof, headquartered in Harelbeke, Belgium, allowing the team to jointly provide total Engineering, Procurement, and Construction - EPC - solutions for ammonia storage across Europe. Engicon nv has expertise in the field of cold tank storage solutions and executing ammonia storage projects for the European chemical and fertilizer industry.

06:08 EDT Sprouts Farmers Market signs nine new NIL deals with female athletes - Sprouts Farmers Market announced nine new individual Name, Image and Likeness - NIL - deals with female athletes from schools in Sprouts communities across the country. To date, Sprouts has executed more than 150 female athlete deals through NIL partnerships as a supporter of women's sports. The 9 new Sprouts female athlete sponsorships are Cameron Brink, Basketball; Hailey Merchant, Gymnastics; Jordan Bowers, Gymnastics; Lauren Gustin, Basketball; Logan Cole, Softball; Sanaa Hebron, Track & Field; Brooke Donabedian, Gymnastics; Sarah Sylvester, Basketball and Volleyball; Alyssa Washington, Softball.

06:06 EDT Tutor Perini unit apparent low bidder for $136M project - Tutor Perini announced that its subsidiary, Lunda Construction Company, has been recently identified by the Illinois Department of Transportation as the apparent low bidder for a bridge replacement and highway improvement project valued at approximately $136M. The project is located on I-64, east of US-1 near Grayville, Illinois. The project crosses the Wabash River, which divides the roadway jurisdiction between White County, Illinois, west of the river, and Posey County, Indiana, east of the river. The improvement is a total of 8,339 feet (1.58 miles) along I-64. The project scope of work includes replacement of the existing dual bridges over the Wabash River, as well as roadway improvements to connect the existing I-64 roadway to the new bridge structures. Contract award is anticipated in the second quarter of 2024 and work is subsequently expected to begin in the third quarter of 2024, with substantial completion anticipated in the fourth quarter of 2029.

06:04 EDT Beam Global granted U.S. patent for wireless charging technology - Beam Global has been granted another new patent by the United States Patent Office that covers the company's wireless charging technology, with the patent title Self-Contained Renewable Inductive Battery Charger. The U.S. Patent Office granted Patent No. US 11,912,144 B2 for Beam Global's wireless/inductive EV ARC that will have the capability of charging EVs wirelessly without the requirement to plug in a charging cable. The new product will be equipped with a wireless power transmitter which delivers electrical energy to charge the EV's batteries through the air and is installed in the engineered ballast and traction pad of the EV ARC system. EV ARC products are ideal infrastructure solutions for inductive or wireless charging because the transmitters can be integrated into the product rather than requiring further disruptive construction and electrical work when installing a similar grid-tied transmitter into a parking space.

05:35 EDT Blue Hat Interactive to refocus into AI financial services - Blue Hat Interactive announced its shift into AI financial services. Deanna Liu, executive director of Golden Strategy, a wholly-owned subsidiary of BHAT, stated that this strategy is a proactive response to the growth in artificial intelligence technology and the evolving market dynamics. BHAT said its strategic shift is not merely a pursuit of new technology but is based on an understanding of the trends in AI technology development, and also the full utilization of BHAT's market resources and technological migration capabilities. Deanna Liu stated, "We believe that the development of AI technology can be divided into three stages: infrastructure construction, the potential for revenue increase, and productivity enhancement. Since 2023, BHAT has undergone comprehensive restructuring, with AI finance being the new focus, responding to the tremendous change brought about by AI in the financial sector." The company said there has been great interest from financial enterprises regarding AI technology applications and BHAT's ability to transition to AI financial services and what that will do for their bottom line.

05:23 EDT PureTech Health announces proposed capital return of $100M - PureTech Health announced a proposed capital return of $100M to its shareholders by way of a tender offer. The capital return of $100M represents approximately 14% of PureTech's market capitalization based on yesterday's closing price. This follows the company's announcement that it will receive approximately $293M gross proceeds from its remaining stake in Karuna. The tender offer will be launched after the publication of the company's FY24 results in April, subject to market conditions, and will require shareholder approval. A circular setting out the full terms of the tender offer and a timetable will be published upon launch. If the full $100M is not returned, then the company intends to return any remainder following the completion of the tender offer, by way of a special dividend.

05:18 EDT Unilever announces plan to separate Ice Cream unit - Unilever announced steps to accelerate its "Growth Action Plan" through the separation of Ice Cream and the launch of a productivity program. The board believes Unilever "should be increasingly focused on a portfolio of unmissably superior brands with strong positions in highly attractive categories that have complementary operating models. Ice Cream has a "very different operating model," and as a result the board has decided that the separation of Ice Cream "best serves the future growth of both Ice Cream and Unilever." Following separation, Unilever "will become a simpler, more focused company, operating four Business Groups across Beauty & Wellbeing, Personal Care, Home Care and Nutrition," the company said in a statement. In addition, Unilever said it will continue to optimize its portfolio within the four business groups towards higher growth spaces and through brands with global reach or significant potential to scale.